EANS-News: Epigenomics AG Presents Colorectal Cancer Blood Test at ESMO Conference
mSEPT9 biomarker facilitates innovative blood test for colorectal cancer PRESEPT Study for colorectal cancer screening with mSEPT9 well on track First European diagnostic laboratory to offer mSEPT9 testing on 1st July Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. new ...